Safety of Guselkumab Treatment for Up to 5 Years in Patients With Moderate to Severe Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety of Guselkumab Treatment for up to 5 Years in Patients With Moderate-to-Severe Psoriasis: Pooled Analyses Across Seven Clinical Trials With Greater Than 8600 Patient-Years of Exposure
Br J Dermatol 2023 Apr 06;[EPub Ahead of Print], MG Lebwohl, JF Merola, K Rowland, M Miller, YW Yang, J Yu, Y You, D Chan, D Thaçi, RG LangleyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.